Advances and applications of binding affinity prediction methods in drug discovery.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Biotechnology Advances

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.biotechadv.2011.08.003PMID 21856406
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Assessing the Performance of the MM/PBSA and MM/GBSA Methods. 1. The Accuracy of Binding Free Energy Calculations Based on Molecular Dynamics Simulations

  2011cited by this paper
• BEAR, a Novel Virtual Screening Methodology for Drug Discovery

  2011cited by this paper
• Assessing the performance of the molecular mechanics/Poisson Boltzmann surface area and molecular mechanics/generalized Born surface area methods. II. The accuracy of ranking poses generated from docking

  2011cited by this paper
• How to improve R&D productivity: the pharmaceutical industry's grand challenge

  2010cited by this paper
• A computational workflow for the design of irreversible inhibitors of protein kinases

  2010cited by this paper
• Absolute binding free energy calculations: On the accuracy of computational scoring of protein–ligand interactions

  2010cited by this paper
• Rigorous Free Energy Calculations in Structure‐Based Drug Design

  2010cited by this paper
• Binding Estimation after Refinement, a New Automated Procedure for the Refinement and Rescoring of Docked Ligands in Virtual Screening

  2009cited by this paper
• Large-scale application of high-throughput molecular mechanics with Poisson-Boltzmann surface area for routine physics-based scoring of protein-ligand complexes.

  2009cited by this paper
• Structure-based virtual ligand screening: recent success stories.

  2009cited by this paper
• WISDOM-II: Screening against multiple targets implicated in malaria using computational grid infrastructures

  2009cited by this paper
• Design and Discovery of Plasmepsin II Inhibitors Using an Automated Workflow on Large‐Scale Grids

  2009cited by this paper
• Efficient drug lead discovery and optimization.

  2009cited by this paper
• Fast and accurate predictions of binding free energies using MM‐PBSA and MM‐GBSA

  2009cited by this paper
• Real World Drug Discovery: A Chemist's Guide to Biotech and Pharmaceutical Research

  2008cited by this paper
• Towards the development of universal, fast and highly accurate docking/scoring methods: a long way to go

  2008cited by this paper
• Computational methods for calculation of ligand-binding affinity.

  2008cited by this paper
• Theoretical and practical considerations in virtual screening: a beaten field?

  2008cited by this paper
• Molecular recognition and binding free energy calculations in drug development.

  2008cited by this paper
• Grid computing in large pharmaceutical molecular modeling.

  2008cited by this paper
• Computational inhibitor design against malaria plasmepsins

  2007cited by this paper
• Calculation of protein-ligand binding affinities.

  2007cited by this paper
• Rapid Estimation of Relative Protein-Ligand Binding Affinities Using a High-Throughput Version of MM-PBSA

  2007cited by this paper
• Molecular dynamics simulations applied to the study of subtypes of HIV-1 protease common to Brazil, Africa, and Asia

  2007cited by this paper
• Validation of an automated procedure for the prediction of relative free energies of binding on a set of aldose reductase inhibitors.

  2007cited by this paper
• Physics-based methods for studying protein-ligand interactions.

  2007cited by this paper
• Structure-based drug design: docking and scoring.

  2007cited by this paper
• Prediction of protein-ligand interactions. Docking and scoring: successes and gaps.

  2006cited by this paper
• Protein-ligand binding affinity predictions by implicit solvent simulations: a tool for lead optimization?

  2006cited by this paper
• A multistep approach to structure-based drug design: studying ligand binding at the human neutrophil elastase.

  2006cited by this paper
• Molecular mechanics methods for predicting protein-ligand binding.

  2006cited by this paper
• A critical assessment of docking programs and scoring functions.

  2006cited by this paper
• Free energy simulations of uncatalyzed DNA replication fidelity: structure and stability of T.G and dTTP.G terminal DNA mismatches flanked by a single dangling nucleotide.

  2006cited by this paper
• High-Throughput Calculation of Protein-Ligand Binding Affinities: Modification and Adaptation of the MM-PBSA Protocol to Enterprise Grid Computing

  2006cited by this paper
• Probing the effect of point mutations at protein-protein interfaces with free energy calculations.

  2006cited by this paper
• Are Automated Molecular Dynamics Simulations and Binding Free Energy Calculations Realistic Tools in Lead Optimization? An Evaluation of the Linear Interaction Energy (LIE) Method

  2006cited by this paper
• Benchmarking sets for molecular docking.

  2006cited by this paper
• Ligand affinities predicted with the MM/PBSA method: dependence on the simulation method and the force field.

  2006cited by this paper
• Scoring binding affinity of multiple ligands using implicit solvent and a single molecular dynamics trajectory: application to influenza neuraminidase.

  2005cited by this paper
• Evaluating the molecular mechanics poisson-boltzmann surface area free energy method using a congeneric series of ligands to p38 MAP kinase.

  2005cited by this paper
• Scoring Functions – the First 100 Years

  2005cited by this paper
• ZINC - A Free Database of Commercially Available Compounds for Virtual Screening

  2005cited by this paper
• Hierarchical database screenings for HIV-1 reverse transcriptase using a pharmacophore model, rigid docking, solvation docking, and MM-PB/SA.

  2005cited by this paper
• Validation and use of the MM-PBSA approach for drug discovery.

  2005cited by this paper
• The Many Roles of Computation in Drug Discovery

  2004cited by this paper
• Free energies of binding of polychlorinated biphenyls to the estrogen receptor from a single simulation

  2003cited by this paper
• Ligand binding affinities from MD simulations.

  2002cited by this paper
• Integration of virtual and high-throughput screening

  2002cited by this paper
• Molecular dynamics and free energy analyses of cathepsin D-inhibitor interactions: insight into structure-based ligand design.

  2002cited by this paper
• Approaches to the description and prediction of the binding affinity of small-molecule ligands to macromolecular receptors.

  2002cited by this paper
• Calculation of relative binding free energy differences for fructose 1,6-bisphosphatase inhibitors using the thermodynamic cycle perturbation approach.

  2001cited by this paper
• Use of MM-PBSA in reproducing the binding free energies to HIV-1 RT of TIBO derivatives and predicting the binding mode to HIV-1 RT of efavirenz by docking and MM-PBSA.

  2001cited by this paper
• Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models.

  2000cited by this paper
• What determines the van der Waals coefficient β in the LIE (linear interaction energy) method to estimate binding free energies using molecular dynamics simulations?

  1999cited by this paper
• Prediction of binding affinities for TIBO inhibitors of HIV-1 reverse transcriptase using Monte Carlo simulations in a linear response method.

  1998cited by this paper
• Calculation of solvation and binding free energy differences between VX-478 and its analogs by free energy perturbation and AMSOL methods

  1996cited by this paper

• Refprogen: a reference-guided molecular generation model with protein-ligand joint representation for property-aware drug design

  2026cites this paper
• Exploring the antipyretic efficacy of Merremia vitifolia (Burm. fil.): from traditional use to molecular docking insights

  2025cites this paper
• Affinity prediction of inhibitor-kinase based on mixture of experts enhanced by multimodal feature semantic analysis.

  2025cites this paper
• Evaluating data partitioning strategies for accurate prediction of protein-ligand binding free energy changes in mutated proteins

  2025cites this paper
• Assessing Computational Strategies for the Evaluation of Antibody Binding Affinities

  2025cites this paper
• Parthenolide Restores Testosterone Biosynthesis After Nanoplastic Exposure by Blocking ROS-Driven NF-κB Nuclear Translocation

  2025cites this paper
• Bioactive fungal metabolites as SIRT2 antagonists: A computational quest for cancer treatment

  2025cites this paper
• Quantum graph learning and algorithms applied in quantum computer sciences and image classification

  2025cites this paper
• Molecular activity of bioactive phytocompounds for inhibiting host cell attachment and membrane fusion interacting with West Nile Virus envelope glycoprotein

  2025cites this paper
• De Novo Drug Design Using Transformer-Based Machine Translation and Reinforcement Learning of an Adaptive Monte Carlo Tree Search

  2024cites this paper
• Anesthetic drug discovery with computer-aided drug design and machine learning

  2024cites this paper
• Detection of Putative Ligand Dissociation Pathways in Proteins Using Site-Identification by Ligand Competitive Saturation

  2024cites this paper
• PQKELP: Projected Quantum Kernel Embedding based Link Prediction in dynamic networks

  2024cites this paper
• Structural, electronic characterization, and antiviral potential of a thiadiazol derivative targeting nucleoprotein of Lassa fever virus: insights from DFT investigation, pharmacokinetic, and molecular docking

  2024cites this paper
• From Graphs to Qubits: A Critical Review of Quantum Graph Neural Networks

  2024cites this paper
• SPIN: SE(3)-Invariant Physics Informed Network for Binding Affinity Prediction

  2024cites this paper
• In silico screening of LRRK2 WDR domain inhibitors using deep docking and free energy simulations

  2024cites this paper
• Recent Advances in Quantum Computing for Drug Discovery and Development

  2024cites this paper
• Polyphenols and extracts from Zingiber roseum (Roxb.) Roscoe leaf mitigate pain, inflammation and pyrexia by inhibiting cyclooxygenase-2: an in vivo and in silico studies

  2024cites this paper
• Development and Benchmarking of Open Force Field 2.0.0: The Sage Small Molecule Force Field

  2023cites this paper
• A Hybrid Quantum-classical Fusion Neural Network to Improve Protein-ligand Binding Affinity Predictions for Drug Discovery

  2023cites this paper
• Exploiting the potential of natural polyphenols as antivirals against monkeypox envelope protein F13 using machine learning and all-atoms MD simulations

  2023cites this paper
• Retrieval-based Controllable Molecule Generation

  2022cites this paper
• Binding thermodynamics and interaction patterns of human purine nucleoside phosphorylase-inhibitor complexes from extensive free energy calculations

  2021cites this paper
• Ligand and structure-based computational designing of multi-target molecules directing FFAR-1, FFAR-4 and PPAR-G as modulators of insulin receptor activity

  2021cites this paper
• Screening of Potent Phytochemical Inhibitors Against SARS-CoV-2 Main Protease: An Integrative Computational Approach

  2021cites this paper
• Structure based designing of thiazolidinone-pyrimidine derivatives as ERK2 inhibitors: Synthesis and in vitro evaluation

  2021cites this paper
• Computer-aided Approaches to Support the Ethnopharmacological Importance of Dillenia pentagyna Roxb.: An In silico Study

  2021cites this paper
• Antidepressant, anxiolytic, antipyretic, and thrombolytic profiling of methanol extract of the aerial part of Piper nigrum: In vivo, in vitro, and in silico approaches

  2021cites this paper
• Structure based virtual screening: Fast and slow

  2021cites this paper
• Antipyretic activity of Caesalpinia digyna (Rottl.) leaves extract along with phytoconstituent’s binding affinity to COX-1, COX-2, and mPGES-1 receptors: In vivo and in silico approaches

  2021cites this paper
• Screening and Prediction of Potential Compounds from Virgin Olive Oil Acting on Proteins Associated with Cancer Disease

  2021cites this paper
• In Silico Design and Molecular Docking Studies of Carbapenem Analogues Targeting Acinetobacter baumannii PBP1A Receptor

  2020cites this paper
• Thermodynamic Insights of Base Flipping in TNA Duplex: Force Fields, Salt Concentrations, and Free-Energy Simulation Methods

  2020cites this paper
• A new optical method to analyze ligand-protein interaction: affinity-based screening system

  2020cites this paper
• Accurate prediction of relative binding affinities of a series of HIV‐1 protease inhibitors using semi‐empirical quantum mechanical charge

  2020cites this paper
• Improving the binding affinity estimations of protein–ligand complexes using machine-learning facilitated force field method

  2020cites this paper
• Prediction of protein-carbohydrate complex binding affinity using structural features

  2020cites this paper
• Computational methods for calculation of protein-ligand binding affinities in structure-based drug design

  2020cites this paper
• SAMPL6 host–guest binding affinities and binding poses from spherical-coordinates-biased simulations

  2019cites this paper
• Single-Molecule Imaging and Computational Microscopy Approaches Clarify the Mechanism of the Dimerization and Membrane Interactions of Green Fluorescent Protein

  2019cites this paper
• Crystal structure of a xylulose 5-phosphate phosphoketolase. Insights into the substrate specificity for xylulose 5-phosphate.

  2019cites this paper
• In Silico Predictions of Endocrine Disruptors Properties

  2019cites this paper
• Refinement and Rescoring of Virtual Screening Results

  2019cites this paper
• Theoretical understanding of the thermodynamics and interactions in transcriptional regulator TtgR-ligand binding.

  2019cites this paper
• Molecular Docking: Shifting Paradigms in Drug Discovery

  2019cites this paper
• Cheminformatics Explorations of Natural Products.

  2019cites this paper
• Generative network complex (GNC) for drug discovery

  2019cites this paper
• Rescoring of docking poses under Occam’s Razor: are there simpler solutions?

  2018cites this paper
• In silico guided development of imine-based inhibitors for resistance-deriving kinases

  2018cites this paper
• Molecular dynamics guided development of indole based dual inhibitors of EGFR (T790M) and c-MET.

  2018cites this paper
• Investigating the Selectivity of Allosteric Inhibitors for Mutant T790M EGFR over Wild Type Using Molecular Dynamics and Binding Free Energy Calculations

  2018cites this paper
• Structure–Activity Relationships of Hexahydrocyclopenta[c]quinoline Derivatives as Allosteric Inhibitors of CDK2 and EGFR

  2018cites this paper
• Selection of protein conformations for structure-based polypharmacology studies.

  2018cites this paper
• Comprehensive and Automated Linear Interaction Energy Based Binding-Affinity Prediction for Multifarious Cytochrome P450 Aromatase Inhibitors

  2017cites this paper
• Using the fast fourier transform in binding free energy calculations

  2017cites this paper
• Computational and Experimental Approaches in Multi-Target Pharmacology

  2017cites this paper
• Exploring the biological consequences of conformational changes in aspartame models containing constrained analogues of phenylalanine

  2016cites this paper
• Advanced molecular dynamics simulation methods for kinase drug discovery.

  2016cites this paper
• An unexpected reversal in the pharmacological stereoselectivity of benzothiadiazine AMPA positive allosteric modulators

  2016cites this paper
• Molecular Insights into the Adsorption Mechanism of Human β-Defensin-3 on Bacterial Membranes.

  2016cites this paper
• S4MPLE—Sampler for Multiple Protein-Ligand Entities: Methodology and Rigid-Site Docking Benchmarking

  2015cites this paper
• Diverse classification models for anti-hepatitis C virus activity of thiourea derivatives

  2015cites this paper
• In silico drug discovery targeting Chikungunya virus

  2015cites this paper
• Prediction of the substrate for nonribosomal peptide synthetase (NRPS) adenylation domains by virtual screening

  2015cites this paper
• In silico tools used for compound selection during target-based drug discovery and development

  2015cites this paper
• Computational polypharmacology comes of age

  2015cites this paper
• EFFECTS OF TEMPERATURE AND MOBILE PHASE COMPOSITION ON THE INTERACTION BETWEEN BERBERINE AND IMMOBILIZED β2-ADRENOCEPTOR BY HIGH PERFORMANCE AFFINITY CHROMATOGRAPHY

  2014cites this paper
• Towards Automated Binding Affinity Prediction Using an Iterative Linear Interaction Energy Approach

  2014cites this paper
• Multiscale Approach to Investigate Self-Assembly of Telodendrimer Based Nanocarriers for Anticancer Drug Delivery

  2014cites this paper
• g_mmpbsa - A GROMACS Tool for High-Throughput MM-PBSA Calculations

  2014cites this paper
• Virtual Screening of PRK1 Inhibitors: Ensemble Docking, Rescoring Using Binding Free Energy Calculation and QSAR Model Development

  2014cites this paper
• Enrichment Factor Analyses on G-Protein Coupled Receptors with Known Crystal Structure

  2013cites this paper
• FEW: A workflow tool for free energy calculations of ligand binding

  2013cites this paper
• New sustainable processes catalyzed by acids with interest in pharmaceutical chemistry

  2013cites this paper
• Scoring multipole electrostatics in condensed-phase atomistic simulations.

  2013cites this paper
• Emerging Topics in Structure-Based Virtual Screening

  2013cites this paper
• Predicting biological activity: Computational approach using novel distance based molecular descriptors

  2012cites this paper
• Elucidation of Allosteric Inhibition Mechanism of 2-Cys Human Peroxiredoxin by Molecular Modeling

  2012cites this paper